Optimising Care During the COVID-19 Pandemic

In the series of videos below, Massey Nematollahi, RN, MScN, OCN, CON^©, Immuno-Oncology Clinical Nurse Specialist at William Osler Health System in Brampton, Ontario, shares perspectives and tips for optimising care during these challenging times.

Optimising Telemedicine

Use of Extended Dosing Intervals for Immunotherapy

Changes in Infusion Practices

Minimising the Impact on Clinical Trials

Educating Staff

Maintaining Patient Relationships Remotely

Care Step Pathways

This section provides stand-alone Care Step Pathways (CSPs) that have been customized for the Canadian audience. We wish to thank Massey Nematollahi, RN, MScN,OCN, CON^©, Immuno-Oncology Clinical Nurse Specialist at William Osler Health System in Brampton, Ontario, for thoughtful review of these materials.

List of CSPs

For Immunotherapy (Checkpoint Inhibitors):
Ipilimumab
Nivolumab
Pembrolizumab
Nivolumab/Ipilimumab

• Skin Toxicities – View Online
• Gastrointestinal Toxicities (Diarrhea and Colitis) – View Online
• Thyroiditis – View Online
• Hepatitis – View Online
• Hypophysitis – View Online
• Adrenal Insufficiency, primary – View Online
• Diabetes – View Online
• Pneumonitis – View Online
• Arthralgia/Arthritis – View Online
• Mucositis/Xerostomia – View Online
• Neuropathy – View Online
• Nephritis – View Online

Patient Resources

Action Plans

This section contains the customizable action plans for patients with different tumor types that have been customized for the Canadian audience.

Decision-Support Tool for Stage III Melanoma

Newly customized for the Canadian audience, this pamphlet is a document to provide/discuss with patients that helps guide their decision making regarding next steps for stage III melanoma. Reviewed by the Save Your Skin Foundation.